Dauntless Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Octreotide Formulation for Intranasal Delivery Read more
Jazz enrolls first patient in JZP-110’s phase 2 trial for excessive sleepiness in PD patients Read more
Quotient Clinical expands into USA through acquisition of SeaView Research, the specialist clinical pharmacology business Read more
Aura Biosciences Receives FDA Clearance of Investigational New Drug Application for Light-activated AU-011 for the Treatment of Ocular Melanoma Read more
Strata Oncology Announces Collaboration with Epizyme to Support Tazemetostat Clinical Development Read more
Portola Pharmaceuticals Signs $150 Million Royalty Agreement with HealthCare Royalty Partners for Development and Commercialization of Andexanet Alfa Read more